Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia

Osaka, Japan & Cambridge, Mass., United States:   HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] is the

READ MORE

Sealmatic Receives “In-Principle Approval” for Issue of 3,93,000 Equity Shares at Rs 637.10 per Equity Share from BSE

Mumbai, Maharashtra, India:  Sealmatic India Ltd., listed on the Bombay Stock Exchange (BSE: BOM: 543782) is pleased to inform that it

READ MORE

Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis

Zug, Switzerland:   Ad hoc announcement pursuant to Art. 53 LR   Approximately 7% of people in the United States

READ MORE

CHMP Recommends Approval of Galderma’s Nemolizumab for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis in the European Union

Zug, Switzerland:   Atopic dermatitis is a common, chronic, and flaring inflammatory skin disease characterized by persistent itch and recurrent

READ MORE

Paratus Announces Approval and Publication of Prospectus

Hamilton, Bermuda, November 12, 2024 – Reference is made to the stock exchange announcement by Euronext Oslo Børs on 5

READ MORE

Uptime Launches Enhanced M&O Stamp of Approval to Accelerate Improvements in Data Center Operational Resiliency

New York, United States:   Uptime Institute today announced its newly enhanced, market-leading, and globally adopted Management & Operations (M&O) Stamp

READ MORE

DOF Group ASA – Approval and publication of prospectus

Austevoll, 5 November 2024: Reference is made to the stock exchange announcement made by DOF Group ASA (“DOF” or the

READ MORE

New Data and Recent Approval in China Cements Galderma’s Leadership in Regenerative Biostimulation

Zug, Switzerland:   Galderma celebrates the 25th anniversary of the approval of Sculptra®, the first proven regenerative biostimulator, with new

READ MORE

With Union Cabinet's recent approval Chennai Metro Rail Project Phase 2 as the ‘Central sector’ project, Central Government to finance almost 65 per cent of the estimated cost

With Union Cabinet's recent approval Chennai Metro Rail Project Phase 2 as the ‘Central sector’ project, Central Government to finance almost 65 per cent of

READ MORE

ABS Issues Approval to Leading Japanese Companies for LCO\2\ Carrier Designs

(HOUSTON) ABS issued an approval in principle (AIP) to leading Japanese companies at Gastech 2024 for two liquid carbon dioxide

READ MORE